Eagle Pharmaceuticals, Inc. Liabilities, Fair Value Adjustment
Eagle Pharmaceuticals, Inc. reported Liabilities, Fair Value Adjustment of $263.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-23.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:LiabilitiesFairValueAdjustment · last filed 2023-03-23
- Eagle Pharmaceuticals, Inc. liabilities, fair value adjustment for fiscal 2022 was $263.00K.
- Eagle Pharmaceuticals, Inc. liabilities, fair value adjustment for fiscal 2021 was $0.00.
- Eagle Pharmaceuticals, Inc. liabilities, fair value adjustment for fiscal 2020 was $0.00.
| Period end | Liabilities, Fair Value Adjustment 12 month |
|---|---|
| 2022-12-31 | $263.00K 10-K · filed 2023-03-23 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-23 |
| 2020-12-31 | $0.00 10-K · filed 2023-03-23 |